298 related articles for article (PubMed ID: 35525976)
1. Do patients with Prader-Willi syndrome have favorable glucose metabolism?
Qian Y; Xia F; Zuo Y; Zhong M; Yang L; Jiang Y; Zou C
Orphanet J Rare Dis; 2022 May; 17(1):187. PubMed ID: 35525976
[TBL] [Abstract][Full Text] [Related]
2. Glucose homeostasis in Prader-Willi syndrome and potential implications of growth hormone therapy.
Zipf WB
Acta Paediatr Suppl; 1999 Dec; 88(433):115-7. PubMed ID: 10626560
[TBL] [Abstract][Full Text] [Related]
3. Circulating Irisin in Children and Adolescents With Prader-Willi Syndrome: Relation With Glucose Metabolism.
Mai S; Fintini D; Mele C; Convertino A; Bocchini S; Grugni G; Aimaretti G; Vietti R; Scacchi M; Crinò A; Marzullo P
Front Endocrinol (Lausanne); 2022; 13():918467. PubMed ID: 35774143
[TBL] [Abstract][Full Text] [Related]
4. Update on Diabetes Mellitus and Glucose Metabolism Alterations in Prader-Willi Syndrome.
Crinò A; Grugni G
Curr Diab Rep; 2020 Feb; 20(2):7. PubMed ID: 32030506
[TBL] [Abstract][Full Text] [Related]
5. Endocrine and metabolic aspects of adult Prader-Willi syndrome with special emphasis on the effect of growth hormone treatment.
Höybye C
Growth Horm IGF Res; 2004 Feb; 14(1):1-15. PubMed ID: 14700552
[TBL] [Abstract][Full Text] [Related]
6. Prevalence and risk factors for type 2 diabetes mellitus with Prader-Willi syndrome: a single center experience.
Yang A; Kim J; Cho SY; Jin DK
Orphanet J Rare Dis; 2017 Aug; 12(1):146. PubMed ID: 28854950
[TBL] [Abstract][Full Text] [Related]
7. Characterization of alterations in carbohydrate metabolism in children with Prader-Willi syndrome.
Krochik AG; Ozuna B; Torrado M; Chertkoff L; Mazza C
J Pediatr Endocrinol Metab; 2006 Jul; 19(7):911-8. PubMed ID: 16995571
[TBL] [Abstract][Full Text] [Related]
8. The metabolic phenotype of Prader-Willi syndrome (PWS) in childhood: heightened insulin sensitivity relative to body mass index.
Haqq AM; Muehlbauer MJ; Newgard CB; Grambow S; Freemark M
J Clin Endocrinol Metab; 2011 Jan; 96(1):E225-32. PubMed ID: 20962018
[TBL] [Abstract][Full Text] [Related]
9. Effects of growth hormone therapy on glucose metabolism and insulin sensitivity indices in prepubertal children with Prader-Willi syndrome.
Crinò A; Di Giorgio G; Manco M; Grugni G; Maggioni A
Horm Res; 2007; 68(2):83-90. PubMed ID: 17337902
[TBL] [Abstract][Full Text] [Related]
10. Irisin and the Metabolic Phenotype of Adults with Prader-Willi Syndrome.
Hirsch HJ; Gross I; Pollak Y; Eldar-Geva T; Gross-Tsur V
PLoS One; 2015; 10(9):e0136864. PubMed ID: 26334732
[TBL] [Abstract][Full Text] [Related]
11. A reduced number of insulin receptors in patients with Prader-Willi syndrome.
Kousholt AM; Beck-Nielsen H; Lund HT
Acta Endocrinol (Copenh); 1983 Nov; 104(3):345-51. PubMed ID: 6356745
[TBL] [Abstract][Full Text] [Related]
12. Suppression of acylated ghrelin during oral glucose tolerance test is correlated with whole-body insulin sensitivity in children with Prader-Willi syndrome.
Paik KH; Choe YH; Park WH; Oh YJ; Kim AH; Chu SH; Kim SW; Kwon EK; Han SJ; Shon WY; Jin DK
J Clin Endocrinol Metab; 2006 May; 91(5):1876-81. PubMed ID: 16507634
[TBL] [Abstract][Full Text] [Related]
13. Altered distribution of adiponectin isoforms in children with Prader-Willi syndrome (PWS): association with insulin sensitivity and circulating satiety peptide hormones.
Haqq AM; Muehlbauer M; Svetkey LP; Newgard CB; Purnell JQ; Grambow SC; Freemark MS
Clin Endocrinol (Oxf); 2007 Dec; 67(6):944-51. PubMed ID: 17666087
[TBL] [Abstract][Full Text] [Related]
14. Visceral adipose tissue and metabolic complications of obesity are reduced in Prader-Willi syndrome female adults: evidence for novel influences on body fat distribution.
Goldstone AP; Thomas EL; Brynes AE; Bell JD; Frost G; Saeed N; Hajnal JV; Howard JK; Holland A; Bloom SR
J Clin Endocrinol Metab; 2001 Sep; 86(9):4330-8. PubMed ID: 11549670
[TBL] [Abstract][Full Text] [Related]
15. Effects of Semaglutide on Glycemic Control and Weight Loss in a Patient with Prader-Willi Syndrome: A Case Report.
Sani E; Prato GD; Zenti MG; Bordugo A; Trombetta M; Bonora E
Endocr Metab Immune Disord Drug Targets; 2022; 22(10):1053-1057. PubMed ID: 35538810
[TBL] [Abstract][Full Text] [Related]
16. Carbohydrate metabolism is not impaired after 3 years of growth hormone therapy in children with Prader-Willi syndrome.
L'Allemand D; Eiholzer U; Schlumpf M; Torresani T; Girard J
Horm Res; 2003; 59(5):239-48. PubMed ID: 12714788
[TBL] [Abstract][Full Text] [Related]
17. Somatropin therapy in adults with Prader-Willi syndrome.
Höybye C; Thorén M
Treat Endocrinol; 2004; 3(3):153-60. PubMed ID: 16026111
[TBL] [Abstract][Full Text] [Related]
18. Metabolic and adipose tissue signatures in adults with Prader-Willi syndrome: a model of extreme adiposity.
Lacroix D; Moutel S; Coupaye M; Huvenne H; Faucher P; Pelloux V; Rouault C; Bastard JP; Cagnard N; Dubern B; Clément K; Poitou C
J Clin Endocrinol Metab; 2015 Mar; 100(3):850-9. PubMed ID: 25478934
[TBL] [Abstract][Full Text] [Related]
19. Adrenarche in Prader-Willi syndrome appears not related to insulin sensitivity and serum adiponectin.
Unanue N; Bazaes R; Iñiguez G; Cortés F; Avila A; Mericq V
Horm Res; 2007; 67(3):152-8. PubMed ID: 17085944
[TBL] [Abstract][Full Text] [Related]
20. Characterization of alterations in glucose and insulin metabolism in Prader-Willi subjects.
Schuster DP; Osei K; Zipf WB
Metabolism; 1996 Dec; 45(12):1514-20. PubMed ID: 8969285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
